AU3524795A - Aromatic ethers derived from indols such as 5ht1-like ligands - Google Patents
Aromatic ethers derived from indols such as 5ht1-like ligandsInfo
- Publication number
- AU3524795A AU3524795A AU35247/95A AU3524795A AU3524795A AU 3524795 A AU3524795 A AU 3524795A AU 35247/95 A AU35247/95 A AU 35247/95A AU 3524795 A AU3524795 A AU 3524795A AU 3524795 A AU3524795 A AU 3524795A
- Authority
- AU
- Australia
- Prior art keywords
- compound
- mmol
- aminoethyl
- indol
- syrup
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
- C07D209/16—Tryptamines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Epoxy Resins (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU55997/99A AU740828B2 (en) | 1994-09-22 | 1999-10-21 | Aromatic ethers derived from indols such as 5HT1-like ligands |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9411305A FR2724933A1 (fr) | 1994-09-22 | 1994-09-22 | Nouveaux ethers aromatiques derives d'indoles utiles comme medicaments |
| FR9411305 | 1994-09-22 | ||
| PCT/FR1995/001220 WO1996009288A1 (fr) | 1994-09-22 | 1995-09-22 | Ethers aromatiques derives d'indoles comme '5ht1-like' ligands |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU55997/99A Division AU740828B2 (en) | 1994-09-22 | 1999-10-21 | Aromatic ethers derived from indols such as 5HT1-like ligands |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU3524795A true AU3524795A (en) | 1996-04-09 |
Family
ID=9467165
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU35247/95A Abandoned AU3524795A (en) | 1994-09-22 | 1995-09-22 | Aromatic ethers derived from indols such as 5ht1-like ligands |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US5852049A (enExample) |
| EP (1) | EP0782568B1 (enExample) |
| JP (1) | JPH10505852A (enExample) |
| AT (1) | ATE216695T1 (enExample) |
| AU (1) | AU3524795A (enExample) |
| CA (1) | CA2200722A1 (enExample) |
| DE (1) | DE69526509T2 (enExample) |
| ES (1) | ES2176337T3 (enExample) |
| FR (1) | FR2724933A1 (enExample) |
| NZ (1) | NZ292934A (enExample) |
| WO (1) | WO1996009288A1 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0749962B1 (en) * | 1995-06-23 | 2000-11-02 | Eli Lilly And Company | 6-substituted-1,2,3,4-tetrahydro-9H-carbazoles and 7-substituted-10H-cyclohepta(7,6-B)indoles |
| US5654431A (en) * | 1996-05-30 | 1997-08-05 | Meng; Qingchang | 5-alkoxy tryptamine derivatives |
| ZA989365B (en) * | 1997-10-15 | 1999-04-15 | Boehringer Mannheim Pharm Corp | Preparation for treating alzheimer's disease |
| US7189753B1 (en) * | 1997-11-06 | 2007-03-13 | Cady Roger K | Preemptive prophylaxis of migraine |
| US6066092A (en) * | 1997-11-06 | 2000-05-23 | Cady; Roger K. | Preemptive prophylaxis of migraine device and method |
| WO2001034146A1 (en) * | 1999-11-08 | 2001-05-17 | Smithkline Beecham Corporation | Novel anti-infectives |
| US7417064B2 (en) | 2002-11-05 | 2008-08-26 | Eli Lilly And Company | 3-aryloxy/thio-3-substituted propanamines and their use in inhibiting serotonin and norepinephrine reuptake |
| EP1587781A1 (en) | 2002-11-05 | 2005-10-26 | Eli Lilly And Company | 3-aryloxy/thio-2,3-substituted propanamines and their use in inhibiting serotonin and norepinephrine reuptake |
| WO2025104490A1 (en) * | 2023-11-14 | 2025-05-22 | Mindset Pharma Inc. | Indole derivatives as serotonergic agents useful for the treatment of disorders related thereto |
| WO2025104491A1 (en) * | 2023-11-14 | 2025-05-22 | Mindset Pharma Inc. | Indole derivatives as serotonergic agents useful for the treatment of disorders related thereto |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2124206C (en) * | 1991-11-25 | 2001-02-27 | John Eugene Macor | Indole derivatives |
| GB9226532D0 (en) * | 1992-12-21 | 1993-02-17 | Smithkline Beecham Plc | Compounds |
| FR2699918B1 (fr) * | 1992-12-30 | 1995-03-17 | Pf Medicament | Ligands sélectifs des récepteurs 5HY1D-5HT1B dérivés d'indole-pipérazine utiles comme médicaments. |
| FR2707639B1 (fr) * | 1993-06-30 | 1995-10-13 | Pf Medicament | Nouveaux composés indoliques dérivés d'arylamines comme ligands sélectifs des récepteurs 5HT1D et 5HT1B. |
| WO1995006638A1 (en) * | 1993-09-01 | 1995-03-09 | Allelix Biopharmaceuticals Inc. | Tryptamine analogs with 5-ht1d selectivity |
-
1994
- 1994-09-22 FR FR9411305A patent/FR2724933A1/fr active Granted
-
1995
- 1995-09-22 ES ES95932042T patent/ES2176337T3/es not_active Expired - Lifetime
- 1995-09-22 EP EP95932042A patent/EP0782568B1/fr not_active Expired - Lifetime
- 1995-09-22 JP JP8510652A patent/JPH10505852A/ja active Pending
- 1995-09-22 AT AT95932042T patent/ATE216695T1/de not_active IP Right Cessation
- 1995-09-22 US US08/809,028 patent/US5852049A/en not_active Expired - Fee Related
- 1995-09-22 CA CA002200722A patent/CA2200722A1/fr not_active Abandoned
- 1995-09-22 AU AU35247/95A patent/AU3524795A/en not_active Abandoned
- 1995-09-22 DE DE69526509T patent/DE69526509T2/de not_active Expired - Fee Related
- 1995-09-22 WO PCT/FR1995/001220 patent/WO1996009288A1/fr not_active Ceased
- 1995-09-22 NZ NZ292934A patent/NZ292934A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE69526509D1 (de) | 2002-05-29 |
| EP0782568A1 (fr) | 1997-07-09 |
| NZ292934A (en) | 1999-05-28 |
| FR2724933B1 (enExample) | 1997-02-07 |
| ATE216695T1 (de) | 2002-05-15 |
| DE69526509T2 (de) | 2002-12-05 |
| JPH10505852A (ja) | 1998-06-09 |
| WO1996009288A1 (fr) | 1996-03-28 |
| FR2724933A1 (fr) | 1996-03-29 |
| ES2176337T3 (es) | 2002-12-01 |
| EP0782568B1 (fr) | 2002-04-24 |
| US5852049A (en) | 1998-12-22 |
| CA2200722A1 (fr) | 1996-03-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL114598A0 (en) | Triazole compounds their preparation and pharmaceutical compositions containing them | |
| AU2614995A (en) | Pharmaceutical compositions comprising an opiate antagonist and calcium salts, their use for the treatment of endorphin-mediated pathologies | |
| TW263499B (enExample) | ||
| HUT72436A (en) | Process for the production of imidazopyridines and pharmaceutical compositions containing them and which are suitable for treating gastro-intestinal diseases | |
| HU9602272D0 (en) | Compositions containing micronized nebivolol | |
| IL114600A (en) | Thiazole and thiadiazole compounds their preparation and pharmaceutical compositions containing them | |
| IL113137A0 (en) | Pharmaceutical compositions containing carboxylic acid derivatives | |
| GB9424766D0 (en) | Pharmaceutical composition | |
| AU1852395A (en) | New tetrasubstituted derivatives of imidazole, their preparation process, the new intermediates obtained, their use as medicaments and the pharmaceutical compositions containing them | |
| FR2724933B1 (enExample) | ||
| AU6611696A (en) | N-(4-substituted-benzyl)-2-aminolactam derivatives | |
| IL115184A0 (en) | Anthracycline derivatives their preparation and use | |
| AU5644296A (en) | Novel heterocyclic chemistry | |
| CY2039B1 (en) | 5-HT 1-like receptor agonist for rectal administration | |
| HU9503099D0 (en) | New piperazinyl-alkylthio-pyrimidine derivatives, pharmaceutical compositions containing them, and process for producing the active components | |
| TW261605B (enExample) | ||
| ZA951963B (en) | N-benzoylmethyl-piperidines | |
| IL108290A0 (en) | Pyrrolidine derivatives, their preparation and medicaments containing them | |
| IL115376A (en) | Pharmaceutical compositions comprising estramustine |